Jeffrey Kaye is the Layton Endowed Professor of Neurology and Biomedical Engineering at Oregon Health and Science University (OHSU). He directs ORCATECH – the National Institute on Aging (NIA) – Oregon Center for Aging and Technology and the NIA – Layton Aging and Alzheimer’s Disease Center at OHSU. Dr. Kaye’s research has focused over the past two decades on the question of why some individuals remain protected from functional decline and dementia with advancing age while others succumb at much earlier times. This work has relied on a number of approaches ranging across the fields of genetics, neuroimaging, physiology and continuous life activity monitoring. He leads several longitudinal studies on aging and clinical trials including the ongoing Oregon Brain Aging Study, the Intelligent Systems for Detection of Aging Changes (ISAAC), the Life Laboratory, the Ambient Independence Measures for Guiding Care Transitions, and the Collaborative Aging (in Place) Research using Technology (CART) studies using ubiquitous, unobtrusive technologies for assessment of older adults in their homes to detect changes signaling imminent functional decline. He is co-principal investigator for the Integrated Analysis of Longitudinal Studies of Aging (IALSA), a worldwide effort to harmonize aging and dementia data for improved analysis. Dr. Kaye has received the Charles Dolan Hatfield Research Award for his work. He is listed in Best Doctors in America. He serves on many national and international panels and review boards in the fields of geriatrics, neurology and technology including as a commissioner for the Center for Aging Services and Technology (CAST), on the Advisory Council of AgeTech West, the International Scientific Advisory Committee of AGE-WELL Canada, and Past Chair of the International Society to Advance Alzheimer’s Research & Treatment (ISTAART). He is an author of over 400 scientific publications and holds several major grant awards from federal agencies, national foundations and industrial sponsors.